Schedule of Investments
July 31, 2022
(Unaudited)
Shares | Value | ||
Common Stocks & Other Equity Interests–97.95% | |||
Australia–1.78% | |||
CSL Ltd. | 751,768 | $152,673,400 | |
Canada–6.54% | |||
Alimentation Couche-Tard, Inc. | 5,318,428 | 237,606,705 | |
CAE, Inc.(a) | 5,247,360 | 138,831,406 | |
Dollarama, Inc. | 3,032,424 | 183,785,425 | |
560,223,536 | |||
China–0.59% | |||
Alibaba Group Holding Ltd.(a) | 4,449,400 | 50,269,853 | |
Denmark–4.40% | |||
Ascendis Pharma A/S, ADR(a)(b) | 505,752 | 43,256,969 | |
Novo Nordisk A/S, Class B | 2,837,255 | 333,683,629 | |
376,940,598 | |||
France–15.99% | |||
Airbus SE | 1,492,140 | 161,356,730 | |
Dassault Systemes SE | 2,901,114 | 124,375,568 | |
Edenred | 2,116,054 | 108,762,651 | |
EssilorLuxottica S.A.(b) | 373,271 | 58,561,500 | |
Hermes International | 238,389 | 326,377,017 | |
Kering S.A. | 130,918 | 75,116,660 | |
L’Oreal S.A. | 300,029 | 113,326,910 | |
LVMH Moet Hennessy Louis Vuitton SE | 358,738 | 249,540,600 | |
Sartorius Stedim Biotech | 377,843 | 151,605,239 | |
1,369,022,875 | |||
Germany–3.58% | |||
CTS Eventim AG & Co. KGaA(a) | 2,372,664 | 129,953,870 | |
SAP SE | 410,656 | 38,062,652 | |
Siemens AG | 281,707 | 31,278,274 | |
Siemens Healthineers AG(c) | 2,087,304 | 106,801,498 | |
306,096,294 | |||
India–4.22% | |||
Dr Lal PathLabs Ltd.(c) | 2,556,534 | 74,424,717 | |
Reliance Industries Ltd. | 9,035,969 | 287,127,980 | |
361,552,697 | |||
Ireland–1.36% | |||
Flutter Entertainment PLC(a) | 1,159,901 | 116,537,823 | |
Italy–1.88% | |||
Davide Campari-Milano N.V. | 14,440,980 | 160,559,062 | |
Japan–8.72% | |||
Benefit One, Inc. | 3,531,100 | 57,259,210 | |
Daikin Industries Ltd. | 841,400 | 147,991,901 | |
Hitachi Ltd. | 1,415,700 | 71,837,962 | |
Hoya Corp. | 741,410 | 74,471,734 | |
Keyence Corp. | 331,584 | 131,587,573 | |
Kobe Bussan Co. Ltd. | 3,116,400 | 88,924,033 | |
Nidec Corp. | 1,344,940 | 93,567,461 | |
Nihon M&A Center Holdings, Inc. | 6,035,000 | 80,617,362 | |
746,257,236 |
Shares | Value | ||
Netherlands–5.64% | |||
Aalberts N.V. | 1,562,319 | $66,969,608 | |
Adyen N.V.(a)(c) | 57,790 | 104,242,498 | |
ASML Holding N.V. | 372,461 | 213,852,473 | |
Shop Apotheke Europe N.V.(a)(b)(c) | 379,312 | 36,719,842 | |
Universal Music Group N.V. | 2,673,260 | 60,721,618 | |
482,506,039 | |||
New Zealand–0.50% | |||
Xero Ltd.(a) | 652,823 | 42,820,114 | |
Spain–1.76% | |||
Amadeus IT Group S.A.(a) | 2,574,623 | 150,227,610 | |
Sweden–7.40% | |||
Atlas Copco AB, Class A(b) | 11,478,160 | 134,181,668 | |
Epiroc AB, Class A | 11,655,316 | 207,339,543 | |
Swedish Match AB | 27,846,738 | 291,717,552 | |
633,238,763 | |||
Switzerland–4.29% | |||
Barry Callebaut AG | 19,004 | 42,143,117 | |
IWG PLC(a) | 15,874,685 | 37,376,062 | |
Lonza Group AG | 110,788 | 67,518,799 | |
Sika AG | 576,036 | 142,558,739 | |
VAT Group AG(c) | 267,573 | 77,796,735 | |
367,393,452 | |||
Taiwan–1.75% | |||
Taiwan Semiconductor Manufacturing Co. Ltd. | 8,758,000 | 149,984,918 | |
United Kingdom–19.07% | |||
Alphawave IP Group PLC(a)(b) | 2,472,595 | 4,075,128 | |
Britvic PLC | 10,225,685 | 107,502,670 | |
Ceres Power Holdings PLC(a)(b) | 1,426,817 | 10,580,683 | |
Compass Group PLC | 9,652,456 | 226,551,995 | |
ConvaTec Group PLC(c) | 22,792,527 | 63,563,314 | |
Entain PLC(a) | 6,756,907 | 99,349,078 | |
Legal & General Group PLC | 23,744,370 | 75,762,235 | |
London Stock Exchange Group PLC | 2,208,517 | 215,534,012 | |
Next PLC | 2,194,338 | 182,843,164 | |
Ocado Group PLC(a) | 12,445,201 | 127,771,001 | |
Rentokil Initial PLC | 23,571,670 | 155,892,406 | |
Rightmove PLC | 15,324,598 | 120,099,303 | |
RS GROUP PLC | 6,988,818 | 88,228,349 | |
Trainline PLC(a)(c)(d) | 31,891,178 | 154,669,531 | |
1,632,422,869 | |||
United States–8.48% | |||
EPAM Systems, Inc.(a)(b) | 540,939 | 188,922,946 | |
Ferguson PLC | 1,153,286 | 145,230,435 | |
James Hardie Industries PLC, CDI | 5,175,813 | 128,006,422 | |
Medtronic PLC | 612,339 | 56,653,604 | |
ResMed, Inc. | 859,467 | 206,719,003 | |
725,532,410 | |||
Total Common Stocks & Other Equity Interests (Cost $5,197,438,448) | 8,384,259,549 |
See accompanying notes which are an integral part of this schedule.
Invesco Oppenheimer International Growth Fund
Shares | Value | ||
Money Market Funds–1.63% | |||
Invesco Government & Agency Portfolio, Institutional Class, 1.71%(d)(e) | 48,453,026 | $48,453,026 | |
Invesco Liquid Assets Portfolio, Institutional Class, 1.67%(d)(e) | 35,425,990 | 35,425,990 | |
Invesco Treasury Portfolio, Institutional Class, 1.66%(d)(e) | 55,374,887 | 55,374,887 | |
Total Money Market Funds (Cost $139,250,971) | 139,253,903 | ||
TOTAL INVESTMENTS IN SECURITIES (excluding Investments purchased with cash collateral from securities on loan)-99.58% (Cost $5,336,689,419) | 8,523,513,452 |
Shares | Value | ||
Investments Purchased with Cash Collateral from Securities on Loan | |||
Money Market Funds–0.71% | |||
Invesco Private Government Fund, 1.77%(d)(e)(f) | 17,131,435 | $17,131,435 | |
Invesco Private Prime Fund, 1.89%(d)(e)(f) | 44,163,385 | 44,163,385 | |
Total Investments Purchased with Cash Collateral from Securities on Loan (Cost $61,297,783) | 61,294,820 | ||
TOTAL INVESTMENTS IN SECURITIES—100.29% (Cost $5,397,987,202) | 8,584,808,272 | ||
OTHER ASSETS LESS LIABILITIES–(0.29)% | (25,038,416) | ||
NET ASSETS–100.00% | $8,559,769,856 |
Investment Abbreviations:
ADR | – American Depositary Receipt |
CDI | – CREST Depository Interest |
Notes to Schedule of Investments:
(a) | Non-income producing security. |
(b) | All or a portion of this security was out on loan at July 31, 2022. |
(c) | Security purchased or received in a transaction exempt from registration under the Securities Act of 1933, as amended (the “1933 Act”). The security may be resold pursuant to an exemption from registration under the 1933 Act, typically to qualified institutional buyers. The aggregate value of these securities at July 31, 2022 was $618,218,135, which represented 7.22% of the Fund’s Net Assets. |
(d) | Affiliated issuer. The issuer is affiliated by having an investment adviser that is under common control of Invesco Ltd. and/or the Investment Company Act of 1940, as amended (the “1940 Act”), defines “affiliated person” to include an issuer of which a fund holds 5% or more of the outstanding voting securities. The Fund has not owned enough of the outstanding voting securities of the issuer to have control (as defined in the 1940 Act) of that issuer. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the nine months ended July 31, 2022. |
Value October 31, 2021 | Purchases at Cost | Proceeds from Sales | Change in Unrealized Appreciation (Depreciation) | Realized Gain (Loss) | Value July 31, 2022 | Dividend Income | |
Investments in Affiliated Money Market Funds: | |||||||
Invesco Government & Agency Portfolio, Institutional Class | $84,257,016 | $440,541,444 | $(476,345,434) | $- | $- | $48,453,026 | $189,704 |
Invesco Liquid Assets Portfolio, Institutional Class | 62,153,130 | 314,672,461 | (341,382,647) | 3,016 | (19,970) | 35,425,990 | 111,137 |
Invesco Treasury Portfolio, Institutional Class | 96,293,733 | 503,475,937 | (544,394,783) | - | - | 55,374,887 | 144,486 |
Investments Purchased with Cash Collateral from Securities on Loan: | |||||||
Invesco Private Government Fund | 90,872,592 | 312,393,969 | (386,135,126) | - | - | 17,131,435 | 100,072* |
Invesco Private Prime Fund | 212,036,049 | 711,118,425 | (878,958,086) | (2,965) | (30,038) | 44,163,385 | 271,478* |
Investments in Other Affiliates: | |||||||
Trainline PLC | 97,285,290 | 37,097,124 | (2,359,767) | 25,113,594 | (2,466,710) | 154,669,531 | - |
Total | $642,897,810 | $2,319,299,360 | $(2,629,575,843) | $25,113,645 | $(2,516,718) | $355,218,254 | $816,877 |
* | Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any. |
(e) | The rate shown is the 7-day SEC standardized yield as of July 31, 2022. |
(f) | The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower’s return of the securities loaned. |
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Invesco Oppenheimer International Growth Fund
Notes to Quarterly Schedule of Portfolio Holdings
July 31, 2022
(Unaudited)
NOTE 1—Additional Valuation Information
Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available or are unreliable. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment’s assigned level:
Level 1 — Prices are determined using quoted prices in an active market for identical assets.
Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others.
Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect the Fund’s own assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.
The following is a summary of the tiered valuation input levels, as of July 31, 2022. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.
Level 1 | Level 2 | Level 3 | Total | |
Investments in Securities | ||||
Australia | $— | $152,673,400 | $— | $152,673,400 |
Canada | 560,223,536 | — | — | 560,223,536 |
China | — | 50,269,853 | — | 50,269,853 |
Denmark | 43,256,969 | 333,683,629 | — | 376,940,598 |
France | — | 1,369,022,875 | — | 1,369,022,875 |
Germany | — | 306,096,294 | — | 306,096,294 |
India | — | 361,552,697 | — | 361,552,697 |
Ireland | — | 116,537,823 | — | 116,537,823 |
Italy | — | 160,559,062 | — | 160,559,062 |
Japan | — | 746,257,236 | — | 746,257,236 |
Netherlands | — | 482,506,039 | — | 482,506,039 |
New Zealand | — | 42,820,114 | — | 42,820,114 |
Spain | — | 150,227,610 | — | 150,227,610 |
Sweden | — | 633,238,763 | — | 633,238,763 |
Switzerland | — | 367,393,452 | — | 367,393,452 |
Taiwan | — | 149,984,918 | — | 149,984,918 |
United Kingdom | — | 1,632,422,869 | — | 1,632,422,869 |
United States | 452,295,553 | 273,236,857 | — | 725,532,410 |
Money Market Funds | 139,253,903 | 61,294,820 | — | 200,548,723 |
Total Investments | $1,195,029,961 | $7,389,778,311 | $— | $8,584,808,272 |
Invesco Oppenheimer International Growth Fund